Victrex was part of Imperial Chemical Industries (ICI) until a management buyout that took place in 1993. After incorporation, Victrex started operations with just 60 employees. Victrex’s specialization in the production of PEEK polymer and selling it to the industrial market led to exponential expansion. In 1995, Victrex floated its shares on the London Stock Exchange, and the company’s new name became Victrex Plc.
The company delegates its operations to several subsidiaries that each serve a specific segment of the market. Primarily, the company manufactures and distributes proprietary PEEK polymers to customers from all over the world. The PEEK polymer materials are essential for correcting knee, spine, dental, and orthopedic problems. Additionally, the company offers solutions that facilitate the proper application of medical devices and their manufacturing. Typical customers for Victrex’s products and services are medical markets, aerospace, electronics, and engineering markets. The company has its headquarters in Thornton Cleveleys, U.K.
Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.